Mucoadhesive formulations: innovations, merits, drawbacks, and future outlook

References

• Abou-Taleb HA, Khallaf RA, Abdel-Aleem JA. 2018. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug Des Devel Ther. 12:3501–3516.
   PubMed Web of Science ®Google Scholar
• Acartürk F. 2009. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 3(3):193–205.
   PubMedGoogle Scholar
• Agarwal S, Aggarwal S. 2015. Mucoadhesive polymeric platform for drug delivery; a comprehensive review. Curr Drug Deliv. 12(2):139–156.
   PubMed Web of Science ®Google Scholar
• Al-Ghananeem AM, Malkawi AH, Crooks PA. 2007. Scopolamine Sublingual Spray: An Alternative Route of Delivery for the Treatment of Motion Sickness. Drug Dev Ind Pharm. 33(5):577–582.
   PubMed Web of Science ®Google Scholar
• Alhalaweh A, Vilinska A, Gavini E, Rassu G, Velaga SP. 2011. Surface thermodynamics of mucoadhesive dry powder formulation of zolmitriptan. AAPS PharmSciTech. 12(4):1186–1192.
   PubMed Web of Science ®Google Scholar
• Alkurt MT, Peker I. 2009. Unusually large submandibular sialoliths: report of two cases. Eur J Dent. 03(02):135–139.
   Google Scholar
• Ahmad FJ, Alam MA, Khan ZI, Khar RK, Ali M. 2008. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm. 58(4):407–419.
   PubMed Web of Science ®Google Scholar
• Anil A, Sudheer P. 2018. Mucoadhesive polymers: A review. J Pharm Res. 17(1):1–9.
   Google Scholar
• Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. 2008. Polymers for Mucoadhesive Drug Delivery System: A Current Status. Drug Dev Ind Pharm. 34(11):1246–1266.
   PubMed Web of Science ®Google Scholar
• Atia NN, Tawfeek HM, Rageh AH, El-Zahry MR, Abdelfattah A, Younis MA. 2019. Novel sublingual tablets of Atorvastatin calcium/trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization. Saudi Pharm J. 27(4):540–549.
   PubMed Web of Science ®Google Scholar
• Avetisov SÉ, Safonova TN, Novikov IA, Pateiuk LS, Griboedova IG. 2014. Ocular surface acidity and buffering system (by studying the conjunctival sac). Vestn Oftalmol. 130(5):5–10.
   PubMedGoogle Scholar
• Babaian EA, Gerasimova GA, Davydov AB, Utyamyshev RI, Khromov GL, Metelitsa VI, Vikhert AM, Savvateev KL, Piotrovsky VK, Novikova EB, inventors; Vsesojuzny Nauchno-Issledovatelsky Tsentr Profilakticheskoi Meditsiny - USSR, assignee. 1989 Jun 27. Antianginal plate for treating ischemic heart disease. United States patent US 4,842,854 A.
   Google Scholar
• Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, Jirapongsananuruk O, Kern R, Meltzer EO, Mullol J, et al. 2014. ICON: chronic rhinosinusitis. World Allergy Organ J. 7:25.
   PubMedGoogle Scholar
• Bagan J, Paderni C, Termine N, Campisi G, Lo Russo L, Compilato D, Di Fede O. 2012. Mucoadhesive polymers for oral transmucosal drug delivery: a review. CPD. 18(34):5497–5514.
   Google Scholar
• Baliga M, Jimmy R, Thilakchand K, Sunitha V, Bhat N, Saldanha E, Rao S, Rao P, Arora R, Palatty P. 2013. Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer. Nutr Cancer. 65(sup1):26–35.
   PubMed Web of Science ®Google Scholar
• Bazzill J, Moon JJ, Fan Y, Sahdev P, inventors; The Regents of the University [US/US], assignee. 2016 Aug 4. Liposomal particles comprising biological molecules and uses thereof. United States patent WO 2016/123,365 Al.
   Google Scholar
• Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. 2010. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol. 58(6):497–507.
   PubMed Web of Science ®Google Scholar
• Boateng J, Okeke O, Khan S. 2015. Polysaccharide based formulations for mucosal drug delivery: a review. Curr Pharm Des. 21(33):4798–4821.
   PubMed Web of Science ®Google Scholar
• Bottoni G, Maffei P, Sforzini A, FedericiCarla M, Silvia C, Giuseppe R, Viscomi C, inventors; Alfa Wasserman SpA Bologna (IT), assignee. 2012 Apr 12. Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations. United State patent US 13,277,130.
   Google Scholar
• Casettari L, Vllasaliu D, Lam JKW, Soliman M, Illum L. 2012. Biomedical applications of amino acid-modified chitosans: a review. Biomaterials. 33(30):7565–7583.
   PubMed Web of Science ®Google Scholar
• Chang Y-L, Yu S-J, Heitman J, Wellington M, Chen Y-L. 2017. New facets of antifungal therapy. Virulence. 8(2):222–236.
   PubMed Web of Science ®Google Scholar
• Chatterjee B, Amalina N, Sengupta P, Mandal UK. 2017. Mucoadhesive polymers and their mode of action: a recent update. J Appl Pharm Sci. 7(5):195–205.
   Google Scholar
• Chaturvedi M, Kumar M, Pathak K. 2011. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Tech Res. 2(4):215–222.
   PubMedGoogle Scholar
• Chen G, Bunt C, Wen J. 2015. Mucoadhesive polymers-based film as a carrier system for sublingual delivery of glutathione: glutathione delivery via sublingual route. J Pharm Pharmacol. 67(1):26–34.
   PubMed Web of Science ®Google Scholar
• Chen N, Niu J, Li Q, Li J, Chen X, Ren Y, Wu G, Liu Y, Shi Y. 2019. Development and evaluation of a new gastroretentive drug delivery system: Nanomicelles-loaded floating mucoadhesive beads. J Drug Delivery Sci Technol. 51:485–492.
   Web of Science ®Google Scholar
• Chonkar A, Nayak U, Udupa N. 2015. Smart polymers in nasal drug delivery. Indian J Pharm Sci. 77(4):367–375.
   PubMed Web of Science ®Google Scholar
• Collins LM, Dawes C. 1987. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res. 66(8):1300–1302.
   PubMed Web of Science ®Google Scholar
• Chou C-Y, Huang C-K, Lu K-W, Horng T-L, Lin W-L. 2013. Investigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical model. Burns JS, Editor. PLoS One. 8(4):e59135.
   PubMed Web of Science ®Google Scholar
• Coghill J, Armstrong R, inventors; Aesica Formulation development Ltd, assignee. 2013. Pharmaceutical powder compositions. United State patent US 20,130,116,244 A1.
   Google Scholar
• Creighton RL, Woodrow KA. 2018. Microneedle-mediated vaccine delivery to the oral mucosa. Adv Healthcare Mater. 8(4):e1801180.
   Web of Science ®Google Scholar
• Cunha AR, Machado RM, Palmeira-de-Oliveira A, Martinez‐de‐Oliveira J, das Neves J, Palmeira-de-Oliveira R. 2014. Characterization of commercially available vaginal lubricants: a safety perspective. Pharmaceutics. 6(3):530–542.
   PubMedGoogle Scholar
• Cutler NR, inventor; 2003. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine. WIPO (PCT) WO 2,003,090,798 A1.
   Google Scholar
• Dassi E, HTM-CMB-2015, Ferretti P, Covello G, Bertorelli R, Denti MA, De Sanctis V, Tett A, Segata N. 2018. The short-term impact of probiotic consumption on the oral cavity microbiome. Sci Rep. 8(1):10476.
   PubMedGoogle Scholar
• da Silva SB, Amorim M, Fonte P, Madureira R, Ferreira D, Pintado M, Sarmento B. 2015. Natural extracts into chitosan nanocarriers for rosmarinic acid drug delivery. Pharm Biol. 53(5):642–652.
   PubMed Web of Science ®Google Scholar
• Devi R, Bhatia M. 2019. Thiol functionalization of flaxseed mucilage: Preparation, characterization and evaluation as mucoadhesive polymer. Int J Biol Macromol. 126:101–106.
   PubMed Web of Science ®Google Scholar
• Djupesland PG. 2013. Nasal drug delivery devices: characteristics and performance in a clinical perspective-a review. Drug Deliv Transl Res. 3(1):42–62.
   PubMed Web of Science ®Google Scholar
• Dong X. 2018. Current strategies for brain drug delivery. Theranostics. 8(6):1481–1493.
   PubMed Web of Science ®Google Scholar
• Dubois AB, Douglas JS, Stitt JT, Mohsenin V. 1998. Production and absorption of nitric oxide gas in the nose. J Appl Physiol. 84(4):1217–1224.
   PubMed Web of Science ®Google Scholar
• England RJ, Homer JJ, Knight LC, Ell SR. 1999. Nasal pH measurement: a reliable and repeatable parameter. Clin Otolaryngol. 24(1):67–68.
   PubMed Web of Science ®Google Scholar
• Erdő F, Bors LA, Farkas D, Bajza Á, Gizurarson S. 2018. Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull. 143:155–170.
   PubMed Web of Science ®Google Scholar
• Escapa IF, Chen T, Huang Y, Gajare P, Dewhirst FE, Lemon KP. 2018. New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the. Human Aerodigestive Tract. mSystems. 3(6):1–20.
   Web of Science ®Google Scholar
• Fangueiro JF, Veiga F, Silva AM, Souto EB. 2016. Ocular drug delivery - new strategies for targeting anterior and posterior segments of the eye. Curr Pharm Des. 22(9):1135–1146.
   PubMed Web of Science ®Google Scholar
• Fedorchak MV, Little SR, Schuman JS, Cugini A, investors; 2014. Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery. WO 2,014,138,085 A1.
   Google Scholar
• Fonseca-Santos B, Chorilli M. 2018. An overview of polymeric dosage forms in buccal drug delivery: State of art, design of formulations and their in vivo performance evaluation. Mater Sci Eng C Mater Biol Appl. 86:129–143.
   PubMed Web of Science ®Google Scholar
• Galgatte UC, Kumbhar AB, Chaudhari PD. 2014. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv. 21(1):62–73.
   PubMed Web of Science ®Google Scholar
• Gan L, Gan Y, Zhu C, Zhang X, Zhu J. 2009. Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results. Int J Pharm. 365(1–2):143–149.
   PubMed Web of Science ®Google Scholar
• Gänger S, Schindowski K. 2018. Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics. 10(3):116–117.
   PubMed Web of Science ®Google Scholar
• Gerton ML, Mann BK, inventors; 2018. Vaginal hydrogel for delivery of therapeutics. United State patent US 20,190,290,582.
   Google Scholar
• Gholizadeh H, Cheng S, Pozzoli M, Messerotti E, Traini D, Young P, Kourmatzis A, Ong HX. 2019. Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders. Expert Opin Drug Deliv. 16(4):453–466.
   PubMed Web of Science ®Google Scholar
• Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. 2014. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 28(2):81–97.
   PubMedGoogle Scholar
• Giovinazzo AJ, Hedden DB, Bryson NJ, inventors; Cynapsus Therapeutics, Inc., assignee. 2016. Sublingual apomorphine. United States patent US 9,326,981.
   Google Scholar
• Govindasamy P, Kesavan BR, Narasimha JK. 2013. Formulation of unidirectional release buccal patches of carbamazepine and study of permeation through porcine buccal mucosa. Asian Pac J Trop Biomed. 3(12):995–1002.
   PubMedGoogle Scholar
• Grabovac V, Guggi D, Bernkop-Schnürch A. 2005. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev. 57(11):1713–1723.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, Sarmento VH, de Freitas O, Lopez R. 2010. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm. 75(2):186–193.
   PubMed Web of Science ®Google Scholar
• Greco JC, McGinity JW, inventors; Greco John C 120 Country Club Lane Mamou Louisiana 70554 Morgan Lee Roy 3839 Ulloa Street New Orleans Louisiana 70119, assignee. 1992. Vaginal progesterone tablet. United State patent US 5,116,619 A.
   Google Scholar
• Gu FX, Liu S, Jones LWJ, investors; University of Waterloo, assignee. 2018a Jan 30. Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof. United State patent US 9,878,000.
   Google Scholar
• Gu FX, Jones LWJ, Shengyan Sandy LIU, University of Waterloo 2018b. Mucoadhesive nanoparticle delivery system. U.S. Patent 9,993,439.
   Google Scholar
• Ham AS, Buckheit RW. 2015. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors. Ther Deliv. 6(2):217–229.
   PubMed Web of Science ®Google Scholar
• Harkema JR, Carey SA, Wagner JG. 2006. The Nose Revisited: A Brief Review of the Comparative Structure, Function, and Toxicologic Pathology of the Nasal Epithelium. Toxicol Pathol. 34(3):252–269.
   PubMed Web of Science ®Google Scholar
• Hauptstein S, Bonengel S, Rohrer J, Bernkop-Schnürch A. 2014. Preactivated thiolated poly(methacrylic acid-co-ethyl acrylate): Synthesis and evaluation of mucoadhesive potential. Eur J Pharm Sci. 63:132–139.
   PubMed Web of Science ®Google Scholar
• Hiorth M, Nilsen S, Tho I. 2014. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics. 6(3):494–511.
   PubMedGoogle Scholar
• Hosseini K, Bowman LM, inventors; 2017 Jan 12. Ocular treatment with reduced intraocular pressure. WIPO (PCT) WO 2,017,007,609 A1.
   Google Scholar
• Hsiao CH, Cacace JL, investors; Schering Corporation, Kenilworth, N.J, assignee. 1988 Jul 5. Buccal formulation. United States patent US 4,755,386.
   Google Scholar
• Illum L, investor; Danbiosyst UK Limited, Nottingham, United Kingdom, assignee. 1999 Aug 10. Nasal drug delivery composition containing nicotine. United States patent US 5,935,604.
   Google Scholar
• Irimia T, Dinu-Pîrvu C-E, Ghica MV, Lupuleasa D, Muntean D-L, Udeanu DI, Popa L. 2018. Chitosan-based In Situ gels for ocular delivery of therapeutics: a state-of-the-art review. Mar Drugs. 16(10):1–23.
   Google Scholar
• Iohara D, Okubo M, Anraku M, Uramatsu S, Shimamoto T, Uekama K, Hirayama F. 2017. Hydrophobically modified polymer/α-cyclodextrin thermoresponsive hydrogels for use in ocular drug delivery. Mol Pharm. 14(8):2740–2748.
   PubMed Web of Science ®Google Scholar
• Jacob J, Moslemy P, Nangia A, Shaked Z, Kreitz M, inventors; 2007 Dec 6. Mucoadhesive oral formulations of high permeability, high solubility drugs. United States patent US 2007/028.1007 A1.
   Google Scholar
• Jagdale S, Shewale N, Kuchekar BS. 2016. Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate. Scientifica. 2016:1–11.
   Web of Science ®Google Scholar
• Jalalvandi E, Shavandi A. 2018. In situ-forming and pH-responsive hydrogel based on chitosan for vaginal delivery of therapeutic agents. J Mater Sci Mater Med. 29(11):158.
   PubMedGoogle Scholar
• Kalam MA, Sultana Y, Samad A, Ali A, Aqil M, Sharma M, Mishra AK. 2008. Gelrite-Based In Vitro Gelation Ophthalmic Drug Delivery System of Gatifloxacin. J Dispersion Sci Technol. 29(1):89–96.
   Web of Science ®Google Scholar
• Kathe K, Kathpalia H. 2017. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 12(6):487–497.
   PubMed Web of Science ®Google Scholar
• Khan AB, Kingsley T, Caroline P. 2017. Sublingual tablets and the benefits of the sublingual route of administration. J Pharm Res. 16(3):257.
   Google Scholar
• Khare A, Grover K, Pawar P, Singh I. 2014. Mucoadhesive polymers for enhancing retention in ocular drug delivery: a critical review. Rev Adhes Adhes. 2(4):467–502.
   Google Scholar
• Kilicarslan M, Ilhan M, Inal O, Orhan K. 2018. Preparation and evaluation of clindamycin phosphate loaded chitosan/alginate polyelectrolyte complex film as mucoadhesive drug delivery system for periodontal therapy. Eur J Pharm Sci. 123:441–451.
   PubMed Web of Science ®Google Scholar
• Kim S, Traore YL, Ho EA, Shafiq M, Kim SH, Liu S. 2018. Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines. Acta Biomater. 82:12–23.
   PubMed Web of Science ®Google Scholar
• Kocak G, Tuncer C, Bütün V. 2017. pH-Responsive polymers. Polym Chem. 8(1):144–176.
   Web of Science ®Google Scholar
• Kurian M, Rao B, Rao A, Shameem VPA. 2016. Effect of vaginal pH on efficacy of dinoprostone gel for labour induction. Int J Reprod Contracept Obstet Gynecol. 5(4):1196–1201.
   Google Scholar
• Kweinor Tetteh E, Rathilal S. 2019. Application of organic coagulants in water and wastewater treatment. In: Organic polymers [Working Title] [Internet]. [place unknown]: IntechOpen; [accessed 2020 Feb 7]. https://www.intechopen.com/online-first/application-of-organic-coagulants-in-water-and-wastewater-treatment.
   Google Scholar
• Laffleur F. 2016. Mucoadhesive therapeutic compositions: a patent review (2011-2014). Expert Opin Ther Pat. 26(3):377–388.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Bacher L, Vanicek S, Menzel C, Muhammad I. 2016. Next generation of buccadhesive excipient: Preactivated carboxymethyl cellulose. Int J Pharm. 500(1–2):120–127.
   PubMedGoogle Scholar
• Laffleur F, Röttges S. 2019. Mucoadhesive approach for buccal application: Preactivated chitosan. Eur Polym J. 113:60–66.
   Web of Science ®Google Scholar
• Laffleur F, Schmelzle F, Ganner A, Vanicek S. 2017. In vitro and ex vivo evaluation of novel curcumin-loaded excipient for buccal delivery. AAPS PharmSciTech. 18(6):2102–2109.
   PubMed Web of Science ®Google Scholar
• Laffleur F, Shahnaz G, Islambulchilar Z, Bernkop-Schnürch A. 2013. Design and in vitro evaluation of a novel polymeric excipient for buccal applications. Future Med Chem. 5(5):511–522.
   PubMed Web of Science ®Google Scholar
• Levine W, Satter A, inventors; Izun Pharmaceuticals Corporation, Dover, DE (US), assignee. 2011 Jul 26. Solid mucoadhesive composition. United States patent US 7,985,430 B2.
   Google Scholar
• Liu Z-P, Zhang L-L, Yang Y-Y, Wu D, Jiang G, Yu D-G. 2018. Preparing composite nanoparticles for immediate drug release by modifying electrohydrodynamic interfaces during electrospraying. Powder Technol. 327:179–187.
   Web of Science ®Google Scholar
• Loftsson T, Stefánsson E. Oculis EHF Reykjavik (IS), inventors; Oculis EHF Reykjavik (IS), assignee. 2011 Feb 22. Cyclodextrin nanotechnology for ophthalmic drug delivery. United States patent. US 7,893,040 B2.
   Google Scholar
• M Ways TM, Lau WM, Khutoryanskiy VV. 2018. Chitosan and its derivatives for application in mucoadhesive drug delivery systems. Polymers (Basel). 10(3):267–211.
   Web of Science ®Google Scholar
• Madden T, Grentzer JM, Secura GM, Allsworth JE, Peipert JF. 2012. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 39(3):217–222.
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Gattani S. 2010. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv. 17(1):19–27.
   PubMed Web of Science ®Google Scholar
• Mahalingam A, Simmons AP, Ugaonkar SR, Watson KM, Dezzutti CS, Rohan LC, Buckheit RW, Kiser PF. 2011. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1. Antimicrob Agents Chemother. 55(4):1650–1660.
   PubMed Web of Science ®Google Scholar
• Mansuri S, Kesharwani P, Jain K, Tekade RK, Jain NK. 2016. Mucoadhesion: A promising approach in drug delivery system. React Funct Polym. 100:151–172.
   Web of Science ®Google Scholar
• Marom Z, Shelhamer J, Kaliner M. 1984. Nasal mucus secretion. Ear Nose Throat J. 63(2):36–37, 41–42, 44.
   PubMedGoogle Scholar
• Mašek J, Mašková E, Lubasová D, Špánek R, Raška M, Turánek J. 2018. Nanofibers in mucosal drug and vaccine delivery. In: Nanomaterials-toxicity, human health and environment. IntechOpen.
   Google Scholar
• Masters DB, Berg EP, inventors; Gel-Del Technologies, Inc., St. Paul, MN (US), assignee. 2013 Sep 10. Mucoadhesive drug delivery devices and methods of making and using thereof. United States patent US 8,529,939 B2.
   Google Scholar
• Mathiowitz E, Chickering D, Jacob JS, inventors; Brown University Research Foundation, Providence, RI (US), assignee. 2001 Mar 6. Bioadhesive microspheres and their use as drug delivery and imaging systems. United States patent US 6,197,346 B1.
   Google Scholar
• Mattern C, Hacker R, inventors; Arrowdean Ltd., Ireland, assignee. 1996 Nov 26. Medicament for increasing the testosterone level. United States patent US 5,578,588 A.
   Google Scholar
• Mehta B, Shah R, Doshi MJB, inventors; Chemicals & Pharmaceuticals Ltd., Worli Bombay (IN), assignee. 2005 Sep 29. Novel stomatological gel. United States patent US 20,050,214,230 A1.
   Google Scholar
• Menchicchi B, Fuenzalida JP, Bobbili KB, Hensel A, Swamy MJ, Goycoolea FM. 2014. Structure of chitosan determines its interactions with mucin. Biomacromolecules. 15(10):3550–3558.
   PubMed Web of Science ®Google Scholar
• Mirkin S, Amadio JM, Bernick BA, inventors; Therapeutics MD Inc., assignee. 2019 Jan 24. Vaginal inserted estradiol pharmaceutical compositions and methods. United States patent US 20,190,022,107 A1
   Google Scholar
• Modi P, Chotai N, Patel H, Suthar R. 2017. Formulation and evaluation of buccal drug delivery system of ketorolac tromethamine using mucoadhesive polymers. Int J Pharm. 9:42–49.
   Google Scholar
• Morrison PWJ, Khutoryanskiy VV. 2014. Advances in ophthalmic drug delivery. Ther Deliv. 5(12):1297–1315.
   PubMedGoogle Scholar
• Nayar B, inventor; Gavis Pharmaceuticals LLC, assignee. 2016 Aug 4. Aqueous nasal spray composition of corticosteroids. United State patent US 14/611,240.
   Google Scholar
• Nelson AL. 2018. An overview of properties of Amphora (Acidform) contraceptive vaginal gel. Expert Opin Drug Saf. 17(9):935–943.
   PubMed Web of Science ®Google Scholar
• Nivoliez A, inventor; Biose, assignee. 2017. Compositions for the treatment of candidoses. France patent FR 3,048,361 A1.
   Google Scholar
• Pandey P, Saini MN. 2017. Mucoadhesive drug delivery system: an overview. PBE. 4(4):183.
   Google Scholar
• Park SY, Yoon JW, Samyang Biopharmaceuticals Corp. 2019. Mucoadhesive pharmaceutical composition and preparation method therefor. U.S. Patent Application 16/067,384.
   Google Scholar
• Patel A, Cholkar K, Agrahari V, Mitra AK. 2013. Ocular drug delivery systems: An overview. WJP. 2(2):47–64.
   Google Scholar
• Patyka M, Malamud D, Weissman D, Abrams WR, Kurago Z. 2015. Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study. PLoS One. 10(7):e0132942.
   PubMed Web of Science ®Google Scholar
• Pauletti G, Soderstrom R, Ritschel W, inventors; UMD Inc., assignee. 2004 Mar 4. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs. United States patent US 2004/0,043,071 A1
   Google Scholar
• Pauletti GM, Harrison DC, Desai KJ, inventors; Femina Pharma Incorporated, Miami, FL (US), assignee. 2012 May 15. Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration. United States patent US 8,178,123 B2.
   Google Scholar
• Pauletti GM, Liu JH, Benet LZ, Ritschel WA, inventors; Femina Pharma Inc, assignee. 2006 Jan 3. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy. United States patent US 6,982,091 B2.
   Google Scholar
• Pendergrass PB, Belovicz MW, Reeves CA. 2003. Surface area of the human vagina as measured from vinyl polysiloxane casts. Gynecol Obstet Invest. 55(2):110–113.
   PubMed Web of Science ®Google Scholar
• Peppas NA, Thomas JB, McGinty J. 2009. Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption. J Biomater Sci Polym Ed. 20(1):1–20.
   PubMed Web of Science ®Google Scholar
• Peyman GA, inventors; Astellas Pharma Inc., Astellas Pharma Inc., assignee. 2002 Dec 3. Treatment of ocular disease. United State patent US 6,489,335 B2.
   Google Scholar
• Piemonte E, Lazos J, Belardinelli P, Secchi D, Brunotto M, Lanfranchi-Tizeira H. 2018. Oral cancer associated with chronic mechanical irritation of the oral mucosa. Med Oral. 23:e151–e160.
   Google Scholar
• Prabhu A, Koland M. 2019. Development and evaluation of an in situ thermogelling system of ofloxacin for controlled ocular delivery. Asian J Pharm Clin Res. 12(3):567–570.
   Google Scholar
• Prasanth VV, Puratchikody A, Mathew ST, Ashok KB. 2014. Effect of permeation enhancers in the mucoadhesive buccal patches of salbutamol sulphate for unidirectional buccal drug delivery. Res Pharm Sci. 9(4):259–268.
   PubMedGoogle Scholar
• Preethi GB, Narendra E. 2015. Formulation and evaluation of in situ mucoadhesive ophthalmic hydrogel for sustained delivery of pefloxacin mesylate. Int J Pharm Pharm Sci. 8(8):345–350.
   Google Scholar
• Preethi S, Shabaraya AR. 2017. Formulation and evaluation of Nifedipine loaded Chitosan microsphers for mucoadhesive drug delivery. IJPSR. 5:5017–5022.
   Google Scholar
• Quadir M, Zia H, Need-Ham TE. 2000. Development and evaluation of nasal formulations of ketorolac. Drug Deliv. 7(4):223–229.
   PubMed Web of Science ®Google Scholar
• Rault I, inventors; Permatec Technologie AG, Zug (CH), assignee. 2001 Jun 5. Bioadhesive tablet. United State patent US 6,242,004 B1.
   Google Scholar
• Regina S, Paul S, inventors; Ohio State Innovation Foundation [US/US]. The Regents of the University of Michigan [US/US], assignee. 2017 Aug 31. Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites. United State patent WO 2017/147,169 Al.
   Google Scholar
• Rodrigues GA, Lutz D, Shen J, Yuan X, Shen H, Cunningham J, Rivers HM. 2018. Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation. Pharm Res. 35(12):245.
   PubMed Web of Science ®Google Scholar
• Rohrer J, Lupo N, Bernkop-Schnürch A. 2018. Advanced formulations for intranasal delivery of biologics. Int J Pharm. 553(1–2):8–20.
   PubMedGoogle Scholar
• Roy H, Brahma CK, Nandi S, Parida KR. 2013. Formulation and design of sustained release matrix tablets of metformin hydrochloride: influence of hypromellose and polyacrylate polymers. Int J App Basic Med Res. 3(1):55–63.
   PubMedGoogle Scholar
• Sanghai P, Nandgude T, Poddar S. 2016. Formulation of Bilayer Benzydamine HCl Patch Targeted For Gingivitis. J Drug Delivery. 2016:1–9.
   Google Scholar
• Sanvordeker DR, Leung SHS, inventors; Watson Laboratories, Inc., Corona, Cahf. assignee. 1990 Feb 13. Mucoadhesive buccal dosage forms. United States patent US 4,900,552.
   Google Scholar
• Sattar M, Sayed OM, Lane ME. 2014. Oral transmucosal drug delivery–current status and future prospects. Int J Pharm. 471(1–2):498–506.
   PubMed Web of Science ®Google Scholar
• Saurí J, Zachariah M, Macovez R, Tamarit JLl, Millán D, Suñé-Pou M, García-Montoya E, Pérez-Lozano P, Miñarro M, Ticó JR, et al. 2017. Formulation and characterization of mucoadhesive controlled release matrix tablets of captopril. J Drug Delivery Sci Technol. 42:215–226.
   Web of Science ®Google Scholar
• Schwarz J, Weisspapir M, inventors; Eastgate Pharmaceuticals Inc., assignee. 2015 Mar 4. Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof. European patent EP 3,113,764 A4.
   Google Scholar
• Shah Y, inventor; Aum Nutrapharm Inc., Trenton, NJ (US), assignee. 2006 Mar 30. Buccal delivery of sea cucumber tablets. United States patent US 2006/0,068,004 A1.
   Google Scholar
• Shaikh M, Nikita DD, Bhamber R. 2012. Permeability enhancement techniques for poorly permeable drugs: a review. J Appl Pharm Sci. 2(6):34–39.
   Google Scholar
• Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. 2011. Mucoadhesive drug delivery systems. J Pharm Bioall Sci. 3(1):89–100.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Singh KK. 2014. Development of mucoadhesive gel microbicide to target mucosal HIV reservoirs. J HIV Clin Sci Res. 2(1):001–007.
   Google Scholar
• Sherafudeen SP, Vasantha PV. 2015. Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharm Sci. 10(6):466–476.
   PubMed Web of Science ®Google Scholar
• Singh R, Sharma D, Garg R. 2017. Review on mucoadhesive drug delivery system with special emphasis on buccal route: an important tool in designing of novel controlled drug delivery system for the effective delivery of pharmaceuticals. J Dev Drugs [Internet]. 06(01) [accessed 2019 Oct 3]. https://www.omicsgroup.org/journals/review-on-mucoadhesive-drug-delivery-system-with-special-emphasis-onbuccal-route-an-important-tool-in-designing-of-novel-controlle-2329-6631-1000169.php?aid=89090.
   Google Scholar
• Singh SK, Adams LA, Bandyopadhyay P, Hasan S, Hawley LC, Sims SM, inventors; Pharmacia LLC, assignee. 2004 Feb 24. Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems. United states patent US 6,696,426 B2.
   Google Scholar
• Slusher B, Rais R, inventors; Johns Hopkins University, assignee. 2018 Nov 29. Intranasal administration of glutamate carboxypeptidase (gcp-ii) inhibitors. United States patent US 15/542,175.
   Google Scholar
• Sonawane M, Shinkar D, Ravindrasaudagar   2017. Mucoadhesive buccal drug delivery system: review article. Int J Curr Pharm Sci. 9(4):1–4.
   Google Scholar
• Sotoyama M, Villanueva MB, Jonai H, Saito S. 1995. Ocular surface area as an informative index of visual ergonomics. Ind Health. 33(2):43–55.
   PubMed Web of Science ®Google Scholar
• Sung HW, Liang HF, Tu H, inventors; GP Medical, Inc., Newport Beach, CA (US); National Tsing Hua University, Hsinchu (TW), assignee. 2009 Oct 20. Nanoparticles for protein drug delivery. United States patent US 7,604,795 B1.
   Google Scholar
• Taghizadeh SM, Soroushnia A, Mirzadeh H, Barikani M. 2009. Preparation and in vitro evaluation of a new fentanyl patch based on acrylic/silicone pressure‐sensitive adhesive blends. Drug Dev Ind Pharm. 35(4):487–498.
   PubMed Web of Science ®Google Scholar
• Tan CW, Chlebicki MP. 2016. Urinary tract infections in adults. Singapore Med J. 57(09):485–490.
   PubMedGoogle Scholar
• Tangri P, Madhav NS. 2011. Oral mucoadhesive drug delivery system: A review. International Journal of Biopharmaceutics. 2:36–46.
   Google Scholar
• Tas C, Ozkan CK, Savaser A, Ozkan Y, Tasdemir U, Altunay H. 2009. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation. Drug Deliv. 16(3):167–175.
   PubMed Web of Science ®Google Scholar
• Teelavath M, Patnaik KR. 2019. Review on Buccal Adhesive Drug Delivery System: A Promising Strategy for Poorly Soluble Drugs. Journal of Drug Delivery and Therapeutics. 9:778–792.
   Google Scholar
• Thoral C, Tchoreloff P, Mazel V, Busignies V, Nivoliez A, inventors; Biose, assignee. 2015 Mar 10. Mucoadhesive sustained-release vaginal tablet. United States patent US 20,170,014,458 A1.
   Google Scholar
• Tsai C-H, Wang P-Y, Lin I-C, Huang H, Liu G-S, Tseng C-L. 2018. Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application. Int J Mol Sci. 19(9):2–20.
   Web of Science ®Google Scholar
• Tsai T-M, inventor; Pharma power biotec co. ltd Taipei (TW), assignee. 2007 Oct 4. Mucoadhesive thermoresponsive medicament-carrier composition. United States patent US 20,070,231,352 A1.
   Google Scholar
• Valle FD, Lorenzi S, Cerini R, Marcolongo G, inventors; Lifegroup S.p.A., Monselice, Italy, assignee. 1999 Mar 2. Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the treatment of skin conditions and as vehicles for active ingredients. United States patent US 5,876,744 A.
   Google Scholar
• Valenti P, Rosa L, Capobianco D, Lepanto MS, Schiavi E, Cutone A, Paesano R, Mastromarino P. 2018. Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense. Front Immunol. 9:376
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Firozian F, Ghassam E. 2015. Formulationoptimization and in vitro evaluation of rapid disintegrating and mucoadhesive sublingual tablets of lorazepam. Farmacia. 63:234–246.
   Web of Science ®Google Scholar
• Vasseur B, Dufour A, Houdas L, Goodwin H, Harries K, Emul NY, Hutchings S. 2017. Comparison of the systemic and local pharmacokinetics of clonidine mucoadhesive buccal tablets with reference clonidine oral tablets in healthy volunteers: an open-label randomised cross-over trial. Adv Ther. 34(8):2022–2032.
   PubMed Web of Science ®Google Scholar
• Verma S, Kaul M, Rawat A, Saini S. 2011. An overview on buccal drug delivery system. IJPSR. 2:1303–1321.
   Google Scholar
• Wang Q, Yu D-G, Zhang L-L, Liu X-K, Deng Y-C, Zhao M. 2017. Electrospun hypromellose-based hydrophilic composites for rapid dissolution of poorly water-soluble drug. Carbohydr Polym. 174:617–625.
   PubMed Web of Science ®Google Scholar
• Wagner G, Ottesen B. 1980. Vaginal blood flow during sexual stimulation. Obstet Gynecol. 56(5):621–624.
   PubMed Web of Science ®Google Scholar
• William L. P., inventor; Northriver Pharm, LLC [US/US], assignee. 2019 Jan 24. Nasal composition comprising a mucoadhesive polymer. United States patent WO/2019/018,338.
   Google Scholar
• Williams P, Rademacher T, Schobel AM, Dadey E, inventors; Midatech Ltd. Aquestive Therapeutics Inc., assignee. 2012 Dec 13. Combination peptide-nanoparticles and delivery systems incorporating same. European patent EP 2,717,858 A1.
   Google Scholar
• Wolk O, Agbaria R, Dahan A. 2014. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Des Devel Ther. 8:1563–1575.
   PubMed Web of Science ®Google Scholar
• Yang G-Z, Li J-J, Yu D-G, He M-F, Yang J-H, Williams GR. 2017. Nanosized sustained-release drug depots fabricated using modified tri-axial electrospinning. Acta Biomater. 53:233–241.
   PubMed Web of Science ®Google Scholar
• Yuan J, Liu T, Li H, Shi T, Xu J, Liu H, Wang Z, Wang Q, Xu L, Wang Y, et al. 2014. Oral sustained-release suspension based on a novel taste-masked and mucoadhesive carrier-ion-exchange fiber. Int J Pharm. 472(1–2):74–81.
   PubMedGoogle Scholar
• Zhang C, Liu Y, Li W, Gao P, Xiang D, Ren X, Liu D. 2019. Mucoadhesive buccal film containing ornidazole and dexamethasone for oral ulcers: in vitro and in vivo studies. Pharm Dev Technol. 24(1):118–126.
   PubMed Web of Science ®Google Scholar